Why Ireland Works for Biotech / Life Sciences
Funding access (100/100) is a standout for Ireland Biotech / Life Sciences companies. The local market has 65 active VC funds, with average seed checks of $900K. Government grant programs include Enterprise Ireland HPSU Grant ($250K) and Enterprise Ireland Competitive Start Fund ($55K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.
Operational ease (86/100) makes Ireland practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated moderate. Company formation takes approximately 5 days at a cost of around $300, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated strong, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.
Corporate tax efficiency (83/100) is one of Ireland's strongest dimensions for Biotech / Life Sciences founders. Key features include a 12.5% statutory corporate tax rate, an IP box regime at 6.25% for qualifying intellectual property income, viable holding company structures for profit extraction. With 76 active tax treaties, cross-border payment withholding tax is manageable for internationally structured businesses.